newsfilter
← Latest News
GlobeNewswire·

Sutro Biopharma Highlights Next-Generation ADC Innovation at Virtual R&D Day

- Company has initiated Phase 1 study with STRO-004, its potential best-in-class Tissue Factor ADC - - Sutro has selected PTK7 as the target for its initial dual-payload candidate, STRO-227 - - Investor webcast today